Status:
COMPLETED
Randomized Clinical Trial Evaluating the Efficacy of Topical Imiquimod in High Grade Cervical Intraepithelial Lesions
Lead Sponsor:
Barretos Cancer Hospital
Collaborating Sponsors:
Farmoquimica S.A.
Conditions:
High Grade Intraepithelial Neoplasia
Cervix Cancer
Eligibility:
FEMALE
25-50 years
Phase:
PHASE2
Brief Summary
Cervical cancer is one of the leading malignancies affecting women, with 311,000 deaths in 2018, most of them seen in underdeveloped countries. This neoplasm has a pre-invasive state, such as cervical...
Eligibility Criteria
Inclusion
- Women between the ages of 25 and 50 with histological diagnosis of CIN 2/3;
- Living 300 km or less from the city of Barretos-São Paulo / Brazil.
Exclusion
- Suspected adenocarcinoma (in situ or invasive) or invading squamous cell carcinoma by colposcopy and/or citology;
- Being pregnant or breastfeeding;
- Women with some immunodeficiency or transplanted;
- Previous treatment history for CIN 2/3.
Key Trial Info
Start Date :
January 1 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 14 2020
Estimated Enrollment :
90 Patients enrolled
Trial Details
Trial ID
NCT03233412
Start Date
January 1 2018
End Date
January 14 2020
Last Update
February 17 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Barretos Cancer Hospital
Barretos, Brazil